One-year outcomes from the STRIDE study of the Indigo aspiration thrombectomy system (Penumbra) for lower-extremity acute limb ischemia (ALI) showed target limb salvage and mortality rates of 88.5% and 12%, respectively.
The data were revealed by Thomas Maldonado, MD, professor of surgery at New York University Langone Medical Center in New York City and national principal investigator of STRIDE, during the 2024 Vascular Annual Meeting (VAM 2024) in Chicago (June 19–22).
The results stand up “very favorably” to historical controls for open surgery from the academic literature showing a target limb salvage rate of 65.4–82% and a mortality rate of 4.9%–42%.
“We see meaningful information both for very good target limb salvage, very low mortality, and the quality of life is significantly improved at one year,” said Maldonado.
